Osteoporosis patients are typically treated with Denosumab injections (e.g. Prolia), which can cause hypocalcemia. As such, patients are often prescribed calcium and vitamin D supplements. However, these supplements can promote stone formation*, and some patients in our community have developed more stones as a result.